TY - JOUR
T1 - Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase
AU - Kim, Hojoong
AU - Yung, Gordon L.
AU - Marsh, James J.
AU - Konopka, Ronald G.
AU - Pedersen, Craig A.
AU - Chiles, Peter G.
AU - Morris, Timothy A.
AU - Channick, Richard N.
PY - 2000
Y1 - 2000
N2 - There is increasing evidence that the pathogenesis and progression of many forms of pulmonary vasculopathy are related to abnormalities in endothelial mediators, including endothelin-1 (ET-1) and nitric oxide (NO). Using a rat model of chronic unilateral pulmonary artery ligation, we investigated the role of ET-1 and NO in postobstructive pulmonary vasculopathy (POPV). Eight months after a left thoracotomy with either left main pulmonary artery ligation (ligated group) or no ligation (sham group), rat lungs, including those contralateral to the ligation (hyperperfused group), were fixed and mounted for histologic sectioning. Morphometric measurements were carried out by computer-assisted image analysis and immunohistochemical staining was performed using specific antibodies against ET-1, ET(A), and EB(B) receptors, and endothelial NO synthase (eNOS). Compared to sham lungs, the ligated lungs showed (1) an increase in muscular, adventitial, and intimal thickness of pulmonary artery; (2) increase in external diameter of the bronchial artery (39.8 ± 2.2 μm vs. 16.8 ± 0.9μm in sham group; P < .005) and number of bronchial arteries per brochiole (3.21 ± μ0.26 vs. 1.86 ± μ0.21 in sham group; P < .001); and (3) increase in the intensity of eNOS and ET(A,B) receptor immunoreactivity. No morphometric or immunohistochemical differences were observed between the hyperperfused and sham lungs. These findings suggest that increased synthesis of endothelial NO may serve as a compensatory mediator in ET-1-mediated vascular remodeling.
AB - There is increasing evidence that the pathogenesis and progression of many forms of pulmonary vasculopathy are related to abnormalities in endothelial mediators, including endothelin-1 (ET-1) and nitric oxide (NO). Using a rat model of chronic unilateral pulmonary artery ligation, we investigated the role of ET-1 and NO in postobstructive pulmonary vasculopathy (POPV). Eight months after a left thoracotomy with either left main pulmonary artery ligation (ligated group) or no ligation (sham group), rat lungs, including those contralateral to the ligation (hyperperfused group), were fixed and mounted for histologic sectioning. Morphometric measurements were carried out by computer-assisted image analysis and immunohistochemical staining was performed using specific antibodies against ET-1, ET(A), and EB(B) receptors, and endothelial NO synthase (eNOS). Compared to sham lungs, the ligated lungs showed (1) an increase in muscular, adventitial, and intimal thickness of pulmonary artery; (2) increase in external diameter of the bronchial artery (39.8 ± 2.2 μm vs. 16.8 ± 0.9μm in sham group; P < .005) and number of bronchial arteries per brochiole (3.21 ± μ0.26 vs. 1.86 ± μ0.21 in sham group; P < .001); and (3) increase in the intensity of eNOS and ET(A,B) receptor immunoreactivity. No morphometric or immunohistochemical differences were observed between the hyperperfused and sham lungs. These findings suggest that increased synthesis of endothelial NO may serve as a compensatory mediator in ET-1-mediated vascular remodeling.
KW - Endothelin-1
KW - Lung
KW - Nitric oxide synthase
KW - Pulmonary vascular remodeling
KW - Rat
UR - https://www.scopus.com/pages/publications/0033917343
U2 - 10.1080/019021400404555
DO - 10.1080/019021400404555
M3 - Article
C2 - 10923246
AN - SCOPUS:0033917343
SN - 0190-2148
VL - 26
SP - 287
EP - 301
JO - Experimental Lung Research
JF - Experimental Lung Research
IS - 4
ER -